|Medical Research Advocates Urge Action to Avert Harm to Nation’s Health|
For immediate release
Washington, D.C., March 1, 2013 – The Ad
|Congressman Steve Stivers Becomes the Newest Co-Chair of the Congressional Biomedical Research Caucus|
Released: February 22, 2013
The Coalition for the Life Sciences, on behalf of the Congressional Biomedical Research Caucus, is pleased to announce Congressman Steve Stivers (R-OH) as the newest co-chair of the Caucus. He joins
President Obama has remained steadfastly supportive of a strong federally backed scientific research enterprise. Even in austere times President Obama has strived to make scientific research a priority in his budgets. Yet, with the unveiling of his FY13 budget proposal on February 13, the scientific community has cause for both celebrate and concern.
National Science Foundation (NSF)
First the good news: President Obama proposed $7.3 billion for the NSF. This is a $340 million increase over FY12—the largest increase in spending for any federal research agency. According to Obama’s budget, NSF's proposed budget includes $5.98 billion, up 5.2%, for its six research directorates and $876 million, up 5.6%, for its education directorate.
In a statement released by the NSF, it states, “this investment in science and engineering reflects an increase in core research funding and moves our nation forward by connecting the science and engineering enterprise with potential economic, societal and educational benefits in areas critical to job creation and a growing economy."
Under this budget, the Directorate for Biological Sciences will be slated for a small increase; however, the NSF’s funding priorities will mainly target advanced manufacturing, clean energy technologies, cybersecurity, and STEM education. These areas are aligned with the Administration’s government-wide priorities in these critical areas.
National Institutes of Health (NIH)
Now the concern: The President’s budget proposes flat funding of $30.7 billion for the NIH. While acknowledging that the nation is in tough budgetary times, flat funding will mean that the NIH budget has failed to keep pace with biomedical inflation for 10 consecutive years, resulting in a budget that, when adjusted for inflation, is 20% smaller than a decade ago.
Under this plan, most of the NIH institutes would receive roughly the same amount of funding as in FY12, except for the new National Center for Advancing Translation Sciences (NCATS), which could see an increase of $64 million to $639 million.
During his State of the Union address, President Obama unequivocally pledged his support for research, stating, “Innovation also demands basic research. Today, the discoveries taking place in our federally financed labs and universities could lead to new treatments that kill cancer cells... Don’t gut these investments in our budget. Don’t let other countries win the race for the future.”
Yet because of ongoing flat-funded NIH budgets, cures will be delayed, jobs will be eliminated, and American leadership and innovation will be jeopardized.
The release of the President’s budget signifies the beginning of the budget and appropriations process. Typically, what the President proposes, the Congress disposes. President Obama’s budget is already considered “DOA” by many leaders on Capitol Hill, allowing Congress to move forward and determine its budget priorities. It is unclear how Congress will fund the medical research enterprise. While historically, science, research, and innovation are seen by members of both political parties as federal investments worth making, many in Congress are committed to slashing all federal program budgets. Additionally, the looming sequestration mandated by the Budget Control Act would mean a further cut of 7 -10% in all federal programs in FY13.
The CLS will continue to work with the Administration and the Congress to ensure the best possible funding outcomes for the medical research enterprise.